浏览全部资源
扫码关注微信
辽宁中医药大学中西医结合学院(辽宁 沈阳 110847)
苗嘉芮,女,博士,讲师,主要从事中医药防治阿尔茨海默病的分子机制研究工作
赵丹玉,教授,博士研究生导师;E-mail:danyu1978@163.com
收稿日期:2024-07-06,
纸质出版日期:2025-07-10
移动端阅览
苗嘉芮,赵丹玉,朱仲康.肾主气化调节阿尔茨海默病小胶质细胞糖代谢重编程延缓免疫衰老的机制[J].上海中医药杂志,2025,59(7):51-54.
MIAO Jiarui,ZHAO Danyu,ZHU Zhongkang.Mechanism of kidney's governance of qi transformation to delay immune senescence through microglial glucose metabolic reprogramming in Alzheimer's disease[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(7):51-54.
苗嘉芮,赵丹玉,朱仲康.肾主气化调节阿尔茨海默病小胶质细胞糖代谢重编程延缓免疫衰老的机制[J].上海中医药杂志,2025,59(7):51-54. DOI: 10.16305/j.1007-1334.2025.z20240706002.
MIAO Jiarui,ZHAO Danyu,ZHU Zhongkang.Mechanism of kidney's governance of qi transformation to delay immune senescence through microglial glucose metabolic reprogramming in Alzheimer's disease[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(7):51-54. DOI: 10.16305/j.1007-1334.2025.z20240706002.
阿尔茨海默病始于肾虚,肾主气化失司,脑髓失养、脑神失用,故而发病。从阿尔茨海默病“脑髓-脑神”核心病机轴出发,探讨肾主气化通过调节小胶质细胞糖代谢重编程延缓免疫衰老的分子机制,以期为本病的治疗提供新思路。糖代谢重编程导致的小胶质细胞免疫衰老是阿尔茨海默病的重要发病机制,其潜在分子机制为糖皮质激素-胰岛素样生长因子1轴失衡,肾主气化功能有助于调节这一过程,从而延缓小胶质细胞免疫衰老。
Alzheimer's disease (AD) is believed to begin with kidney deficiency, which leads to dysfunction of kidney's governance of qi transformation, resulting in insufficient nourishment of the brain marrow and functional impairment of brain spirit, thereby initiating the disease. Based on the core pathogenesis axis of "brain marrow-brain spirit" in AD, this paper explores the molecular mechanism by which kidney's governance of qi transformation may influence the microglial glucose metabolic reprogramming in AD to delay immune senescence, with the aim of providing new insights for AD treatment. Glucose metabolic reprogramming-induced immune senescence of microglia is a crucial pathogenic mechanism in AD. The potential molecular mechanism is related to the imbalance of the glucocorticoid-insulin-like growth factor 1 axis. The kidney's governance of qi transformation helps regulate this process, thus delaying immune senescence in microglia.
SENGOKU R . Aging and Alzheimer's disease pathology [J]. Neuropathology , 2020 , 40 ( 1 ): 22 - 29 .
SCHELTENS P , DE STROOPER B , KIVIPELTO M , et al . Alzheimer's disease [J]. Lancet , 2021 , 397 ( 10284 ): 1577 - 1590 .
FAKHOURY M . Microglia and astrocytes in Alzheimer's disease: implications for therapy [J]. Curr Neuropharmacol , 2018 , 16 ( 5 ): 508 - 518 .
RAWJI K S , MISHRA M K , MICHAELS N J , et al . Immunosenescence of microglia and macrophages: impact on the ageing central nervous system [J]. Brain , 2016 , 139 ( Pt 3 ): 653 - 661 .
LI Y , XIA X H , WANG Y , et al . Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease [J]. J Neuroinflammation , 2022 , 19 ( 1 ): 248 .
BUTTERFIELD D A , HALLIWELL B . Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease [J]. Nat Rev Neurosci , 2019 , 20 ( 3 ): 148 - 160 .
张学凯 , 时晶 , 倪敬年 , 等 . 阿尔茨海默病证候级联假说探讨 [J]. 中医杂志 , 2019 , 60 ( 9 ): 741 - 744 .
薛静 , 陈志刚 , 李楠楠 , 等 . 从脑髓-脑神-脑气角度分期辨治阿尔茨海默病 [J]. 中医杂志 , 2021 , 62 ( 19 ): 1684 - 1689 .
张紫嫣 , 黄雅薇 , 张新雪 , 等 . “肾髓系统”的理论渊源 [J]. 世界科学技术-中医药现代化 , 2017 , 19 ( 5 ): 744 - 748 .
周玲 , 王平 , 彭圆 . 中医“肾脑系统”的构建及其现代生物学基础 [J]. 中华中医药杂志 , 2018 , 33 ( 2 ): 422 - 425 .
张帅 , 韦云 , 李浩 . 基于肾脑相关理论探讨阿尔茨海默病患者中枢神经再生 [J]. 中医杂志 , 2018 , 59 ( 2 ): 120 - 123 .
张梦雪 , 曲彦洁 , 李倩 , 等 . 阿尔茨海默病患者证候演变规律及fNIRS脑血流动力学特征研究 [J]. 中医杂志 , 2024 , 65 ( 6 ): 600 - 608 .
刘淑芳 , 陈功香 . 基于脑科学的动态元认知监控理论新发展 [J]. 教育生物学杂志 , 2023 , 11 ( 1 ): 1 - 6 .
高雅新 , 王彤 , 祁鸣 , 等 . 认知障碍患者背外侧前额叶功能连接与认知-步行能力的关系研究 [J]. 中国康复医学杂志 , 2021 , 36 ( 12 ): 1487 - 1495 .
周亚 , 赵春生 , 张煦 , 等 . 基于“正气存内,邪不可干”论治心力衰竭的免疫损伤 [J]. 中医药临床杂志 , 2022 , 34 ( 11 ): 2024 - 2028 .
王凯 , 昝树杰 , 徐家淳 , 等 . 中医“脑髓”的现代生物学基础探讨 [J]. 中华中医药杂志 , 2024 , 39 ( 2 ): 566 - 570 .
常远 , MAGETA S M , 李倪博文 , 等 . 调控小胶质细胞干预阿尔茨海默病的研究进展 [J]. 中国药科大学学报 , 2024 , 55 ( 5 ): 603 - 612 .
孙元芳 , 赖嘉敏 , 王永宽 , 等 . 基于“肾脑相济”理论探讨安神补脑液防治阿尔茨海默病 [J]. 中草药 , 2024 , 55 ( 16 ): 5692 - 5703 .
贺文彬 , 张俊龙 , 陈乃宏 . 基于海马-HPA轴负反馈调控机制对中医肾脑关系的理论分析 [J]. 中华中医药杂志 , 2016 , 31 ( 9 ): 3426 - 3428 .
MEHLS O , HIMMELE R , HÖMME M , et al . The interaction of glucocorticoids with the growth hormone-insulin-like growth factor axis and its effects on growth plate chondrocytes and bone cells [J]. J Pediatri Endocrinol Metab , 2001 , 14 ( Suppl 6 ): 1475 - 1482 .
SHANGGUAN Y , LI X , QIN J , et al . Positive programming of the GC-IGF1 axis mediates adult osteoporosis susceptibility in male offspring rats induced by prenatal dexamethasone exposure [J]. Biochem Pharmacol , 2022 , 206 : 115264 .
HU W , YUAN C , LUO H , et al . Glucocorticoid-insulin-like growth factor 1(GC-IGF1) axis programming mediated hepatic lipid-metabolic in offspring caused by prenatal ethanol exposure [J]. Toxicol Lett , 2020 , 331 : 167 - 177 .
NAGARAJA T N , PATEL P , GORSKI M , et al . In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain [J]. Cerebrospinal Fluid Res , 2005 , 2 : 1 - 15 .
刘珍珠 , 刘修超 , 佟常青 , 等 . 元气、原气、真气、正气的内涵及相互关系探析 [J]. 中医杂志 , 2022 , 63 ( 5 ): 401 - 406 .
OKAWA E R , GUPTA M K , KAHRAMAN S , et al . Essential roles of insulin and IGF-1 receptors during embryonic lineage development [J]. Mol Metab , 2021 , 47 : 101164 .
WANG J , ZHU Q , CAO D , et al . Bone marrow-derived IGF1 orchestrates maintenance and regeneration of the adult skeleton [J]. Proc Natl Acad Sci U S A , 2023 , 120 ( 1 ): e2203779120 .
CHUKWUMA C . Insulin and ageing: Interventions for healthier lifestyle and prolonged lifespan [J]. J Bio Med Res Rep , 2023 , 2 ( 1 ): 6 .
XU L Z , LI F Y , LI B Q , et al . Decreased levels of insulin-like growth factor-1 are associated with Alzheimer's disease:A meta-analysis [J]. J Alzheimers Dis , 2021 , 82 ( 3 ): 1357 - 1367 .
MYHRE C L , THYGESEN C , VILLADSEN B , et al . Microglia express insulin-like growth factor-1 in the hippocampus of aged APPswe/PS1 ΔE9 transgenic mice [J]. Front Cell Neurosci , 2019 , 13 : 308 .
SUÁREZ-CALVET M , KLEINBERGER G , ARAQUE CABALLERO M Á , et al . sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers [J]. EMBO Mol Med , 2016 , 8 ( 5 ): 466 - 476 .
CANET G , PINEAU F , ZUSSY C , et al . Glucocorticoid receptors signaling impairment potentiates amyloid‑β oligomers-induced pathology in an acute model of Alzheimer's disease [J]. FASEB J , 2020 , 34 ( 1 ): 1150 - 1168 .
DAVILA D , PIRIZ J , TREJO J L , et al . Insulin and insulin-like growth factor I signalling in neurons [J]. Front Biosci , 2007 , 12 ( 9 ): 3194 - 3202 .
马迎民 , 徐德成 , 范吉平 . 中医“后天之精气培补肾精”的现代医学机制 [J]. 中医杂志 , 2016 , 57 ( 21 ): 1805 - 1809 .
姚泰 , 曹济民 , 樊小力 , 等 . 生理学 [M]. 北京 : 人民卫生出版社 , 2011 .
李斌 , 纪立金 , 闵寅 , 等 . 从《黄帝内经》的思维方法探讨“气”和能量的相关性 [J]. 中华中医药杂志 , 2019 , 34 ( 11 ): 5033 - 5036 .
张茂林 , 张六通 , 邱幸凡 , 等 . 论线粒体与中医“气”的关系 [J]. 中国中医基础医学杂志 , 2001 , 7 ( 4 ): 60 - 61 .
HAKUNO F , TAKAHASHI S I . 40 years of IGF1: IGF1 receptor signaling pathways [J]. J Mol Endocri , 2018 , 61 ( 1 ): 69 - 86 .
FREUDE S , SCHILBACH K , SCHUBERT M . The role of IGF1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease [J]. Curr Alzheimer Res , 2009 , 6 ( 3 ): 213 - 223 .
GABBOUJ S , RYHÄNEN S , MARTTINEN M , et al . Altered insulin signaling in Alzheimer's disease brain-special emphasis on PI3K-AKT pathway [J]. Front Neurosci , 2019 , 13 : 629 .
马晓伟 . Aβ 1-42 诱导有氧糖酵解通过EphA2/p38 MAPK通路促进小胶质细胞炎症反应 [D]. 石家庄 : 河北医科大学 , 2022 .
MA X , ZHANG Y , GOU D , et al . Metabolic reprogramming of microglia enhances proinflammatory cytokine release through epha2/p38 mapk pathway in Alzheimer's disease [J]. J Alzheimers Dis , 2022 , 88 ( 2 ): 771 - 785 .
WANG Q , DUAN L , LI X , et al . Glucose metabolism, neural cell senescence and Alzheimer's disease [J]. Int J Mol Sci , 2022 , 23 ( 8 ): 4351 .
YANG S , QIN C , HU Z W , et al . Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system [J]. Neurobiol Dis , 2021 , 152 : 105290 .
李忠 , 白宗科 , 张丽伟 , 等 . 免疫衰老及其相关疾病的防治 [J]. 中国肿瘤生物治疗杂志 , 2020 , 27 ( 4 ): 341 - 350 .
MELKONIAN E A , SCHURY M P . Biochemistry, Anaerobic Glycolysis [M]. Treasure Island (FL) : StatPearls Publishing , 2019 .
BAIK S H , KANG S , LEE W , et al . A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease [J]. Cell Metab , 2019 , 30 ( 3 ): 493 - 507 .
0
浏览量
0
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构